Sysmex Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SSMXY research report →
Companywww.sysmex.co.jp
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
- CEO
- Hisashi Ietsugu
- IPO
- 2011
- Employees
- 10,042
- HQ
- Kobe, JP
Price Chart
Valuation
- Market Cap
- $5.38B
- P/E
- 23.87
- P/S
- 1.70
- P/B
- 1.68
- EV/EBITDA
- 7.69
- Div Yield
- 2.78%
Profitability
- Gross Margin
- 51.14%
- Op Margin
- 12.43%
- Net Margin
- 7.09%
- ROE
- 7.27%
- ROIC
- 7.50%
Growth & Income
- Revenue
- $530.16B · 4.23%
- Net Income
- $37.59B · -29.95%
- EPS
- $60.72 · -29.45%
- Op Income
- $65.92B
- FCF YoY
- 13.39%
Performance & Tape
- 52W High
- $18.10
- 52W Low
- $8.12
- 50D MA
- $8.63
- 200D MA
- $10.36
- Beta
- 0.65
- Avg Volume
- 263.49K
Get TickerSpark's AI analysis on SSMXY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SSMXY Coverage
We haven't published any research on SSMXY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SSMXY Report →